tradingkey.logo
tradingkey.logo
Search

Xenon Pharmaceuticals Inc

XENE
Add to Watchlist
62.670USD
-1.520-2.37%
Close 07-31 16:00ETQuotes delayed by 15 min
6.06BMarket Cap
LossP/E TTM

XENE Financials

See Xenon Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Xenon Pharmaceuticals Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-1.14
Revenue / Forecast
--/1.25M
Period
FY2025 Earnings
Revenue(YoY)
7.50M
--
EPS(YoY)
-4.36
-45.09%
Analyst Rating
BUY
2026/08/01
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-41.68%-1.17
-56.77%-1.31
-42.35%-1.15
-43.86%-1.07
-33.82%-0.83
-31.04%-0.84
-9.74%-0.81
-3.49%-0.75
2.70%-0.62
-12.33%-0.64
---0.73
---0.72
---0.63
---0.57
---1.49
----
----
----
----
----
Revenue
-100.00%0.00
--0.00
--0.00
--0.00
--7.50M
----
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-98.38%132.00K
-75.83%536.00K
101.15%8.77M
-27.44%3.74M
23.95%8.12M
-83.43%2.22M
Net Profit
-57.27%-102.30M
-60.25%-105.26M
-44.76%-90.90M
-46.24%-84.71M
-35.71%-65.05M
-46.81%-65.69M
-29.57%-62.79M
-22.05%-57.92M
-14.87%-47.93M
-19.70%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-115.41%-41.73M
-49.05%-37.38M
-146.30%-37.15M
-44.33%-31.16M
-26.27%-19.37M
-109.45%-25.08M
-75.28%-15.08M
-12598.82%-21.59M
Net Margin
----
---4612.13%
----
----
---867.29%
----
----
----
----
----
----
----
----
----
---932.56%
----
----
----
----
----
Gross Margin
----
--100.00%
----
----
--100.00%
----
----
----
----
----
----
----
----
----
--100.00%
----
----
----
----
----
Revenue
-100.00%0.00
--0.00
--0.00
--0.00
--7.50M
----
----
----
----
--0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
-98.38%132.00K
-75.83%536.00K
101.15%8.77M
-27.44%3.74M
23.95%8.12M
-83.43%2.22M
Operating profit
-54.43%-112.33M
-41.68%-109.77M
-30.76%-96.34M
-36.36%-94.23M
-23.20%-72.74M
-44.29%-77.48M
-32.31%-73.68M
-24.23%-69.10M
-20.37%-59.04M
-23.92%-53.70M
-46.04%-55.68M
-83.49%-55.62M
-182.41%-49.05M
-74.45%-43.33M
-144.44%-38.13M
-34.75%-30.32M
-8.16%-17.37M
-92.20%-24.84M
-60.82%-15.60M
-3382.66%-22.50M
Net Profit
-57.27%-102.30M
-60.25%-105.26M
-44.76%-90.90M
-46.24%-84.71M
-35.71%-65.05M
-46.81%-65.69M
-29.57%-62.79M
-22.05%-57.92M
-14.87%-47.93M
-19.70%-44.74M
-30.45%-48.46M
-52.32%-47.46M
-115.41%-41.73M
-49.05%-37.38M
-146.30%-37.15M
-44.33%-31.16M
-26.27%-19.37M
-109.45%-25.08M
-75.28%-15.08M
-12598.82%-21.59M
Current assets
95.68%1.11B
-11.75%560.65M
-27.21%480.14M
-31.29%500.25M
-20.03%565.54M
-1.50%635.26M
24.22%659.64M
33.69%728.09M
32.60%707.20M
7.44%644.96M
-18.20%531.01M
-31.48%544.62M
-2.25%533.35M
7.38%600.30M
153.27%649.18M
197.95%794.80M
92.62%545.62M
207.52%559.02M
31.57%256.31M
28.86%266.75M
Total current liabilities
24.31%39.81M
17.43%41.79M
29.10%38.34M
5.63%33.05M
44.13%32.03M
30.50%35.59M
20.01%29.70M
11.10%31.29M
-1.19%22.22M
20.13%27.27M
59.26%24.74M
105.00%28.16M
181.77%22.49M
58.51%22.70M
20.85%15.54M
-8.32%13.74M
-30.54%7.98M
-3.11%14.32M
-24.01%12.86M
-28.84%14.98M
Total assets
86.58%1.39B
-20.67%633.16M
-27.28%607.84M
-23.72%674.28M
-19.12%743.28M
-17.27%798.14M
24.56%835.90M
29.07%884.01M
27.67%919.02M
27.93%964.80M
-13.50%671.09M
-15.17%684.90M
28.99%719.87M
31.84%754.15M
193.48%775.81M
193.90%807.38M
91.99%558.06M
202.35%572.01M
32.76%264.35M
30.40%274.71M
Total liabilities
24.59%48.99M
18.89%51.40M
26.86%48.33M
0.85%40.30M
25.53%39.32M
17.24%43.24M
10.41%38.09M
3.96%39.96M
-4.86%31.32M
12.95%36.88M
52.03%34.50M
78.08%38.44M
103.16%32.92M
48.58%32.65M
47.23%22.69M
21.77%21.59M
12.59%16.21M
23.23%21.97M
-9.89%15.41M
-17.07%17.73M
Total equity
90.04%1.34B
-22.94%581.76M
-29.87%559.51M
-24.89%633.98M
-20.70%703.96M
-18.65%754.90M
25.32%797.81M
30.57%844.05M
29.22%887.70M
28.61%927.92M
-15.47%636.59M
-17.73%646.46M
26.78%686.94M
31.17%721.50M
202.53%753.12M
205.78%785.79M
96.13%541.85M
220.99%550.03M
36.76%248.94M
35.76%256.98M
Net operating income
-44.19%-88.90M
-49.82%-81.48M
-40.29%-71.75M
-96.56%-64.23M
-33.48%-61.65M
-31.84%-54.38M
-21.12%-51.15M
1.63%-32.68M
-34.22%-46.19M
-16.76%-41.25M
-38.91%-42.23M
-96.95%-33.22M
-86.73%-34.41M
-70.59%-35.33M
-102.59%-30.40M
-28.99%-16.87M
11.01%-18.43M
-57.92%-20.71M
-34.54%-15.01M
-21.21%-13.08M
Net investment
-1280.19%-407.28M
-36.35%62.70M
1846.01%38.53M
-25.70%82.26M
179.90%34.51M
142.11%98.50M
-95.88%1.98M
296.81%110.72M
-192.65%-43.19M
-1893.19%-233.94M
120.52%48.03M
2018.60%27.90M
195.36%46.62M
94.55%-11.74M
-1603.03%-234.10M
-83.92%1.32M
11.28%-48.89M
-598.70%-215.43M
186.37%15.57M
-25.08%8.19M
Net financing
73141.79%843.01M
836.00%113.54M
--2.36M
--65.00K
--1.15M
-96.26%12.13M
----
----
--0.00
5400133.33%324.01M
4121.46%29.51M
-100.00%0.00
-100.00%0.00
-100.00%6.00K
-85.31%699.00K
243044.14%269.89M
-93.37%7.88M
719795.56%323.95M
--4.76M
100.66%111.00K

FAQs

What is the total revenue of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 7.50M, with a year-on-year change of 7.50M.

What are the current assets of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its current assets were 560.65M, with a year-on-year change of -11.75.

What are the total assets of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its total assets of Xenon Pharmaceuticals Inc were 633.16M, with a year-on-year change of -20.67.

What are the total liabilities of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Xenon Pharmaceuticals Inc were 51.40M, with a year-on-year change of 18.89.

What is the total equity of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its total equity of Xenon Pharmaceuticals Inc was 581.76M, with a year-on-year change of -22.94.

What is the net operating income of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Xenon Pharmaceuticals Inc was -373.07M, with a year-on-year change of -33.57.

What is the net investment of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its net investment of Xenon Pharmaceuticals Inc was 218.00M, with a year-on-year change of 32.12.

What is the net financing of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its net financing of Xenon Pharmaceuticals Inc was 117.11M, with a year-on-year change of 865.48.

What is the Earnings Per Share (EPS) of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.36, with a year-on-year change of -45.09.

What is the net income of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its net income was -345.91M, with a year-on-year change of -47.62.

What is the Return on Equity (ROE) of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its Return on Equity (ROE) was -51.76, with a year-on-year change of -85.85.

What is the Return on Assets (ROA) of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -48.34, with a year-on-year change of -81.82.

What is the operating profit of Xenon Pharmaceuticals Inc?

According to Xenon Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -373.07M, with a year-on-year change of -33.57.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.